Relative to CSII, an implantable, programmable pump supplying insulin intravenously or intraperitoneally provided excellent glycaemic control with few hypoglycaemic episodes. It is sited subcutaneously in the lower left abdomen and only required filling on average once every two months.
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.